ArticleEuropean journal of haematology2022

Pomalidomide plus dexamethasone for patients with relapsed or refractory multiple myeloma: Final results of the non-interventional study POSEIDON and comparison with the pivotal phase 3 clinical trials.

Tobias Dechow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.